Table 1.
Neonate | Gestational age at birth (weeks) | Deliverya | ESBL Source | ESBL resistance mechanism | Days in NICU prior to positive result | Infected/colonised | Feedingb | Status at time of discharge from NICU | Repeat ESBL testing post outbreak |
---|---|---|---|---|---|---|---|---|---|
1 | 28 + 2 | CS | Rectal | Unknown | 46 | Colonised | EBM | Alive | Not performed |
2 (index case) | 34 + 5 | VD | Right buttock, right eye, urine, rectal | CTX-M | 8 | Infectedc | EBM | Alive | Not performed |
3 | 36 + 3 | CS | Rectal | CTX-M | 8 | Colonised | EBM | Alive | Not performed |
4 | 36 + 3 | CS | Rectal | CTX-M | 8 | Colonised | EBM | Alive | Not performed |
5 | 35 + 4 | CS | Rectal | CTX-M | 7 | Colonised | Formula | Alive | Not performed |
6 | 30 + 6 | VD | Rectal, urine | CTX-M | 6 | Infectedd | EBM | Alive | ESBL positive rectal swab September 2013 |
aCS: caesarean section, VD: vaginal delivery
bEBM: expressed breast milk
cOphthalmic, skin/soft tissue infection
dUrosepsis